Brief: Tongfang Kontafarma's Unit To Sell 55.43% Stake In SPF (Beijing) Biotechnology At RMB159.7 Mln
06/04/2022 16:05
April 6 (Reuters) - Tongfang Kontafarma Holdings Ltd
1312.HK :
* UNIT TO SELL 55.43% EQUITY INTEREST IN SPF (BEIJING)
BIOTECHNOLOGY CO AT RMB159.7 MILLION
* EXPECTS TO RECORD GAIN ON DISPOSAL OF ABOUT RMB47.5
MILLION
Further company coverage: 1312.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr